- Anthropic told everyone Mythos was dangerous because it's proficiency with biologics and cyber security
- Anthropic didn't release Mythos like everything else. They released a neutered fable. They didn't get rid of Mythos
- Anthropic opens a lab in SF
There was always a quesiton of "will the labs stop releasing their models and start building around them instead?" Yes - they already have. Anthropic is a biologic and cyber security company, in addition to intelligience.
Personally I wonder if they've been holding back a lot. Opus 5.5 was a good release after a little stagnation. Open AI releases good models and everyone says Anthropic sucks and -- Oh would you look at that - a better model finally and all of a sudden.
Either that or they are throwing spaghetti at the wall to see what sticks ahead of the IPO. After all, if solving all diseases is the “total addressable market” then that sure helps.
Even if your comment is taken at face value (which it shouldn’t), they aren’t the only stakeholders.
I presume you are instead alluding to drug companies not wanting to cure diseases, since they then have no market to sell drugs into. But even then the discussion is more nuanced.
nonethewiser · · focus · HN ↗
- Anthropic told everyone Mythos was dangerous because it's proficiency with biologics and cyber security
- Anthropic didn't release Mythos like everything else. They released a neutered fable. They didn't get rid of Mythos
- Anthropic opens a lab in SF
There was always a quesiton of "will the labs stop releasing their models and start building around them instead?" Yes - they already have. Anthropic is a biologic and cyber security company, in addition to intelligience.
Personally I wonder if they've been holding back a lot. Opus 5.5 was a good release after a little stagnation. Open AI releases good models and everyone says Anthropic sucks and -- Oh would you look at that - a better model finally and all of a sudden.
jbs789 · · focus · HN ↗
Time will tell.
downrightmike · · focus · HN ↗
jbs789 · · focus · HN ↗
I presume you are instead alluding to drug companies not wanting to cure diseases, since they then have no market to sell drugs into. But even then the discussion is more nuanced.